Hepatocellular Carcinoma
Conditions
Interventions
None listed
Sponsors
Department of Gastroenterological, Breast and Endocrine Surgery, Yamaguchi University Graduate School of Medicine
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1)Patients with a confirmed diagnosis of hepatocellular carcinoma who are scheduled to undergo initial liver resection 2)Patients evaluated as "borderline resectable" or "resectable" based on preoperative assessments, including tumor size, number, and presence or absence of vascular invasion 3)Patients aged 18 years or older at the time of consent 4)No restriction on sex 5)Patients who have received a full explanation of the study and have provided written informed consent of their own free will
Exclusion criteria
Exclusion criteria: 1)Patients with synchronous (double) cancers 2)Patients with a contrast agent allergy 3)Patients with other severe comorbidities (e.g., unstable angina, poorly controlled diabetes) 4)Patients deemed inappropriate for participation in this study by the principal investigator
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Changes from baseline in liver function (ALBI score, Child-Pugh score, and ICGR15 value) | — |
Secondary
| Measure | Time frame |
|---|---|
| Operative time, blood loss, postoperative complications (Clavien-Dindo classification), overall survival, and recurrence-free survival. | — |
Countries
Japan
Contacts
Public ContactYukio Tokumitsu
Yamaguchi University Graduate School of Medicine Department of Gastroenterological, Breast and Endocrine Surgery
Outcome results
None listed